HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)
Clinical trials for HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA) explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA) trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy trial targets tough blood cancers and anemia
Disease control Recruiting nowThis early-phase study is testing a new cell therapy called GT801 in adults with advanced blood cancers or autoimmune anemia that has not responded to standard treatments. The main goals are to check if the treatment is safe and to see early signs of whether it helps control the …
Matched conditions: HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Universal cell injection tested as new weapon against tough blood cancers
Disease control Recruiting nowThis early-stage study is testing a new, 'off-the-shelf' cell therapy called GT719 in adults with B-cell blood cancers (like certain leukemias and lymphomas) that have come back or not responded to other treatments. The main goals are to see if the treatment is safe, what side ef…
Matched conditions: HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New cell therapy trial targets tough blood cancers
Disease control Recruiting nowThis early-stage study is testing a new cell-based treatment called GT719 injection for adults with B-cell blood cancers that have come back or haven't responded to other treatments. The main goals are to find a safe dose and see if the treatment helps shrink the cancer. About 46…
Matched conditions: HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)
Phase: PHASE1, PHASE2 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC